| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 709 | 459 | +54.6% |
| EBITDA | 31.9 | 22.6 | +40.8% |
| EBITDA margin | 4.5% | 4.9% | −0.5 pts |
| Profit before tax | 20.6 | 13.3 | +55.2% |
| Net profit | 15.2 | 9.9 | +53.5% |
| EPS | ₹2.42 | ₹1.58 | +53.2% |
| Tap a line for its trend | Q2 FY27Sep 2026 | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 |
|---|
| 709 | 578 | 574 | 491 | 459 | 427 | 393 | |
| 0.9 | 1.1 | 0.6 | 0.9 | 2.7 | 1.1 | 1.3 | |
| 710 | 579 | 575 | 492 | 461 | 428 | 394 | |
Expenses | |||||||
| 618 | 498 | 490 | 414 | 381 | 369 | 332 | |
| 7.0 | 6.1 | 8.9 | 7.5 | 10.8 | 0.0 | 1.5 | |
| 0.6 | −0.6 | 0.5 | −0.3 | 1.3 | −3.7 | 1.0 | |
| 18.9 | 18.2 | 17.5 | 16.4 | 16.0 | 15.6 | 14.2 | |
| 2.3 | 2.2 | 2.4 | 2.2 | 3.0 | 2.5 | 2.1 | |
| 9.8 | 9.4 | 9.3 | 9.0 | 9.1 | 7.9 | 6.8 | |
| 32.8 | 28.3 | 27.5 | 27.9 | 26.6 | 24.8 | 22.0 | |
| 689 | 561 | 556 | 477 | 448 | 416 | 379 | |
| 31.9 | 28.2 | 29.7 | 25.1 | 22.6 | 21.7 | 22.7 | |
| 22.0 | 18.8 | 20.4 | 16.1 | 13.6 | 13.8 | 15.9 | |
Profit | |||||||
| 20.6 | 17.7 | 18.5 | 14.8 | 13.3 | 12.3 | 15.1 | |
| 0.0 | 0.0 | 0.0 | −1.4 | 0.0 | 0.0 | 0.0 | |
| 20.6 | 17.7 | 18.5 | 13.5 | 13.3 | 12.3 | 15.1 | |
| 5.5 | 4.6 | 5.4 | 3.6 | 3.4 | 3.0 | 3.8 | |
| −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | 0.2 | −0.1 | |
| 5.4 | 4.5 | 5.3 | 3.6 | 3.4 | 3.2 | 3.7 | |
| 15.2 | 13.2 | 13.3 | 9.9 | 9.9 | 9.2 | 11.4 | |
| 15.2 | 13.2 | 13.3 | 9.9 | 9.9 | 9.2 | 11.4 | |
| −0.1 | −0.1 | −0.1 | −0.2 | 0.0 | 0.0 | 0.2 | |
| 15.2 | 13.2 | 13.2 | 9.7 | 9.9 | 9.2 | 11.6 | |
Per share | |||||||
| ₹2.42 | ₹2.10 | ₹2.11 | ₹1.58 | ₹1.58 | ₹1.46 | ₹1.81 | |
| ₹2.42 | ₹2.10 | ₹2.11 | ₹1.58 | ₹1.58 | ₹1.46 | ₹1.81 | |
Other comprehensive income — detail | |||||||
| −0.1 | −0.1 | −0.1 | −0.2 | 0.0 | 0.0 | 0.2 | |
| — | 0.1 | 0.1 | 0.2 | — | −0.0 | −0.2 | |
| −0.1 | — | — | — | — | — | — | |
| −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.1 | |
Per share — as-filed variants | |||||||
| ₹2.42 | ₹2.10 | ₹2.11 | ₹1.58 | ₹1.58 | ₹1.46 | ₹1.81 | |
| ₹2.42 | ₹2.10 | ₹2.11 | ₹1.58 | ₹1.58 | ₹1.46 | ₹1.81 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||||||
| 1,578 | — | 1,335 | — | 1,215 | — | 993 | |
Derived — gross profit (revenue − materials − purchases − Δ inventories) | |||||||
| 83.6 | 74.6 | 74.6 | 69.5 | 65.3 | 62.2 | 58.9 | |
| 11.8% | 12.9% | 13.0% | 14.1% | 14.2% | 14.6% | 15.0% | |
Adjusted (ex-exceptional items) — derived | |||||||
| 20.6 | 17.7 | 18.5 | 14.8 | 13.3 | 12.3 | 15.1 | |
| 0.0 | 0.0 | 0.0 | −1.4 | 0.0 | 0.0 | 0.0 | |
| 15.2 | 13.2 | 13.3 | 10.9 | 9.9 | 9.2 | 11.4 | |
| ₹2.42 | ₹2.10 | ₹2.11 | ₹1.74 | ₹1.58 | ₹1.46 | ₹1.81 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | Q2 FY27 30/09/2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 392.9 | 427.1 | 458.6 | 491.0 | 574.3 | 577.8 | 709.2 | |
| Other Income | 1.3 | 1.1 | 2.7 | 0.9 | 0.6 | 1.1 | 0.9 | |
| Total Income | 394.2 | 428.1 | 461.3 | 492.0 | 574.9 | 578.9 | 710.1 | |
| Expenses | ||||||||
| + Cost of Materials Consumed | 331.5 | 368.6 | 381.2 | 414.4 | 490.2 | 497.7 | 618.1 | |
| + Purchases of Stock-in-Trade | 1.5 | 0.0 | 10.8 | 7.5 | 8.9 | 6.1 | 7.0 | |
| + Changes in Inventories | 1.0 | -3.7 | 1.3 | -0.3 | 0.5 | -0.6 | 0.6 | |
| + Employee Benefit Expense | 14.2 | 15.6 | 16.0 | 16.4 | 17.5 | 18.2 | 18.9 | |
| + Finance Costs | 2.1 | 2.5 | 3.0 | 2.2 | 2.4 | 2.2 | 2.3 | |
| + Depreciation & Amortisation | 6.8 | 7.9 | 9.1 | 9.0 | 9.3 | 9.4 | 9.8 | |
| + Other Expenses | 22.0 | 24.8 | 26.6 | 27.9 | 27.5 | 28.3 | 32.8 | |
| Total Expenses | 379.1 | 415.8 | 448.0 | 477.1 | 556.3 | 561.2 | 689.5 | |
| EBITDA | 22.7 | 21.7 | 22.6 | 25.1 | 29.7 | 28.2 | 31.9 | |
| EBIT | 15.9 | 13.8 | 13.6 | 16.1 | 20.4 | 18.8 | 22.0 | |
| Profit | ||||||||
| PBT before Exceptional Items | 15.1 | 12.3 | 13.3 | 14.8 | 18.5 | 17.7 | 20.6 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | -1.4 | 0.0 | 0.0 | 0.0 | |
| Pretax Income | 15.1 | 12.3 | 13.3 | 13.5 | 18.5 | 17.7 | 20.6 | |
| + Current Tax | 3.8 | 3.0 | 3.4 | 3.6 | 5.4 | 4.6 | 5.5 | |
| + Deferred Tax | -0.1 | 0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | |
| Tax Expense | 3.7 | 3.2 | 3.4 | 3.6 | 5.3 | 4.5 | 5.4 | |
| Net Income | 11.4 | 9.2 | 9.9 | 9.9 | 13.3 | 13.2 | 15.2 | |
| + Net Income — Continuing Ops | 11.4 | 9.2 | 9.9 | 9.9 | 13.3 | 13.2 | 15.2 | |
| + Other Comprehensive Income | 0.2 | 0.0 | 0.0 | -0.2 | -0.1 | -0.1 | -0.1 | |
| Total Comprehensive Income | 11.6 | 9.2 | 9.9 | 9.7 | 13.2 | 13.2 | 15.2 | |
| Per Share | ||||||||
| Basic EPS | 1.81 | 1.46 | 1.58 | 1.58 | 2.11 | 2.10 | 2.42 | |
| Diluted EPS | 1.81 | 1.46 | 1.58 | 1.58 | 2.11 | 2.10 | 2.42 | |
| Other Comprehensive Income — detail | ||||||||
| + Other Comprehensive Income | 0.2 | 0.0 | 0.0 | -0.2 | -0.1 | -0.1 | -0.1 | |
| + Tax on Items NOT to be Reclassified | -0.2 | -0.0 | — | 0.2 | 0.1 | 0.1 | — | |
| + Items to be Reclassified to P&L | — | — | — | — | — | — | -0.1 | |
| + Tax on Items to be Reclassified | 0.1 | 0.0 | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | |
| Per Share — as-filed variants | ||||||||
| Basic EPS — Continuing Operations | 1.81 | 1.46 | 1.58 | 1.58 | 2.11 | 2.10 | 2.42 | |
| Diluted EPS — Continuing Operations | 1.81 | 1.46 | 1.58 | 1.58 | 2.11 | 2.10 | 2.42 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||||
| Related-party Transactions — During the Period | 993.1 | — | 1,215.2 | — | 1,335.3 | — | 1,577.7 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||||
| Gross Profit | 58.9 | 62.2 | 65.3 | 69.5 | 74.6 | 74.6 | 83.6 | |
| Gross Margin % | 14.99 | 14.55 | 14.24 | 14.14 | 12.99 | 12.92 | 11.78 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||||
| Pretax Income (Adjusted, as filed) | 15.1 | 12.3 | 13.3 | 14.8 | 18.5 | 17.7 | 20.6 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | -1.4 | 0.0 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | 11.4 | 9.2 | 9.9 | 10.9 | 13.3 | 13.2 | 15.2 | |
| EPS Adj | 1.81 | 1.46 | 1.58 | 1.74 | 2.11 | 2.10 | 2.42 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
| Filed Debt Equity | — | — | 0.64 | — | 0.48 | — | — | |
| Filed Dscr | — | — | 3.32 | — | 3.73 | — | — | |
| Filed Iscr | — | — | 8.48 | — | 10.27 | — | — | |
| Paid Up Equity Capital | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | |
Filed with NSE on Tuesday, 27 October 2026 at 1:31 pm IST
Bharat Seats (NSE: BHARATSE) reported its Q2 FY27 results (July–September 2026) on Tuesday, 27 October 2026 at 1:31 pm IST. Consolidated net profit was ₹15.2 crore, up 53.5% from ₹9.9 crore in Q2 FY26 and up 15.1% from ₹13.2 crore in Q1 FY27. Revenue from operations was ₹709 crore, up 54.6% year on year and up 22.7% from the previous quarter.
Consolidated net profit was ₹15.2 crore, up 53.5% from ₹9.9 crore in Q2 FY26 and up 15.1% from ₹13.2 crore in Q1 FY27.
Revenue from operations was ₹709 crore, up 54.6% year on year and up 22.7% from the previous quarter.
Basic earnings per share were ₹2.42, against ₹1.58 in Q2 FY26.
Both grew from a year earlier: net profit was up 53.5% at ₹15.2 crore and revenue was up 54.6% at ₹709 crore. The operating margin was 3.1%, up 0.1 percentage points from 3.0% a year earlier. Against Q1 FY27, net profit was up 15.1% and revenue up 22.7%.
Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹22 crore, a margin of 3.1%, against 3.3% in Q1 FY27 and 3.0% in Q2 FY26. EBITDA was ₹31.9 crore, 4.5% of revenue.
Consolidated net profit for the first half of FY27 (April–September 2026) was ₹28.4 crore, up 49.0% from ₹19.1 crore in the same months a year earlier. Revenue from operations was ₹1,287 crore, up 45.3%.
Bharat Seats' net profit margin was 2.1% in Q2 FY27 (net profit as a share of revenue from operations), against 2.2% in Q2 FY26 (unchanged). For FY26 as a whole it was 2.2%.
Net profit by quarter: ₹9.9 crore in Q3 FY26, ₹13.3 crore in Q4 FY26, ₹13.2 crore in Q1 FY27 and ₹15.2 crore in Q2 FY27. That is ₹51.6 crore over the four quarters. Revenue from operations: ₹491 crore, ₹574 crore, ₹578 crore and ₹709 crore.
On Tuesday, 27 October 2026 at 1:31 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 5 November 2025.
Consolidated net profit was ₹42.2 crore in FY26 (April 2025–March 2026), up 29.1% from ₹32.7 crore in FY25.
Revenue from operations was ₹1,951 crore in FY26 (April 2025–March 2026), up 51.4% from ₹1,289 crore in FY25.
Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.
From Bharat Seats' own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.